A. J. Van de Wouw

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study

E. Van Cutsem, C. Borg, H. Wasan, 2022, British Journal of Cancer.